Loading stock data…
Pediatrix Medical Group, Inc. (MD)
$24.69+0.01 (+0.04%)
Market ClosedLast close Jun 29
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pediatrix Medical Group, Inc. in the Healthcare sector is trading at $24.69 with a market capitalization of $1.8B. Wall Street consensus targets $23.17 (6 analysts), implying a -6.2% move over the next 12 months. The stock is currently near its 52-week high of $24.99, remaining 17.7% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -6.2% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $476.20M↓ | $493.77M↑ | $492.88M↑ | $468.84M↑ | $458.36M |
| Gross Profit | $112.96M↓ | $125.98M↓ | $140.35M↑ | $124.73M↑ | $102.64M |
| Operating Income | $46.58M↓ | $54.67M↓ | $74.00M↑ | $63.70M↑ | $38.71M |
| Net Income | $29.57M↓ | $33.68M↓ | $71.71M↑ | $39.26M↑ | $20.74M |
Peer Comparison
JNJUNHPFE
Fundamentals
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications wi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.79B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
10.60
Beta
Defensive asset. Lower volatility than the S&P 500.
0.71
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
19.83%
Volume
Today's trading volume
580,266
Recent News
3 Profitable Stocks Walking a Fine Line
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
3 Russell 2000 Stocks with Warning Signs
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
3 Hyped Up Stocks with Open Questions
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
MOH Wins Illinois Medicaid Contract, Reinforcing Long-Term Stability
Molina Healthcare secures an Illinois Medicaid managed care contract starting in 2027, reinforcing its position in a key market and supporting long-term growth.
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit
HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.